Experienced in DICER1 Syndrome

Dr. Jayne S. Gurtler

Hematology Oncology | Hematology | Oncology
Crescent City Physicians Inc
2820 Canal St, 
New Orleans, LA 
 (894.8 mi)
Accepting New Patients
Experienced in DICER1 Syndrome
Crescent City Physicians Inc
2820 Canal St, 
New Orleans, LA 
 (894.8 mi)
OverviewInsuranceLocationsClinical Research

Overview

Jayne Gurtler is a Hematologist Oncology specialist and a Hematologist in New Orleans, Louisiana. Dr. Gurtler and is rated as an Experienced provider by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are Paget Disease of the Breast, Lung Cancer, Inflammatory Breast Cancer, and Pleuropulmonary Blastoma. Dr. Gurtler is currently accepting new patients.

Her clinical research consists of co-authoring 6 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in LA
Hospital Affiliations
East Jefferson General Hospital
West Jefferson Medical Center
Touro Infirmary
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Aetna
  •  UnitedHealthcare
  •  Humana

Locations

CRESCENT CITY PHYSICIANS INC
2820 Canal St, New Orleans, LA 70119
Other Locations
CRESCENT CITY PHYSICIANS INC
100 W Harrison Ave, Suite 101, New Orleans, LA 70124
CRESCENT CITY PHYSICIANS INC
2121 Ridgelake Dr, Metairie, LA 70001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, PK, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, PK, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
Enrollment Status: Completed
Publish Date: May 03, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) as a Third-line Treatment of Unresectable, Recurrent, or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) as a Third-line Treatment of Unresectable, Recurrent, or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 24, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 1 Trial of CV301 in Combination With Anti- PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
A Phase 1 Trial of CV301 in Combination With Anti- PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: February 27, 2020
Intervention Type: Biological
Study Phase: Phase 1
A Phase I, First-in-Human, Dose Escalation Trial of MSC2363318A, a Dual p70S6K/Akt Inhibitor, in Subjects With Advanced Malignancies
A Phase I, First-in-Human, Dose Escalation Trial of MSC2363318A, a Dual p70S6K/Akt Inhibitor, in Subjects With Advanced Malignancies
Enrollment Status: Completed
Publish Date: September 19, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

6 Total Publications

Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
Journal: The oncologist
Published: July 26, 2022
Similar Doctors
Experienced in DICER1 Syndrome
Dr. Richard C. Kline
Gynecologic Oncology | Oncology
Experienced in DICER1 Syndrome
Dr. Richard C. Kline
Gynecologic Oncology | Oncology
1514 Jefferson Hwy, 
New Orleans, LA 
 (3.4 mi)
504-842-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Kline is a Gynecologic Oncologist and an Oncologist in New Orleans, Louisiana. Dr. Kline and is rated as a Distinguished provider by MediFind in the treatment of DICER1 Syndrome. His top areas of expertise are Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Ovarian Cancer, Testicular Yolk Sac Tumor, and Hysterectomy. Dr. Kline is currently accepting new patients.

Experienced in DICER1 Syndrome
Dr. Katrina S. Wade
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Experienced in DICER1 Syndrome
Dr. Katrina S. Wade
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

South Louisiana Medical Associates

1990 Industrial Blvd, 
Houma, LA 
 (45.2 mi)
985-868-9300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Katrina Wade is a Gynecologic Oncologist and an Oncologist in Houma, Louisiana. Dr. Wade and is rated as a Distinguished provider by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are Cervical Cancer, Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, and Ovarian Cancer. Dr. Wade is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile